EPZ032597
EPZ032597 is a selective and noncompetitive SMYD2 inhibitor with an IC50 value of 16 nM. EPZ032597 is promising for research of pancreatic ductal adenocarcinoma[1][2].
Product Specifications
CAS Number
1887193-58-9
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/epz032597.html
Smiles
O=C(C1=CN(C2CC2)N=N1)NC3CN(C3)CC4=CN(CC5=CC=CC=C5)N=C4
Molecular Formula
C20H23N7O
Molecular Weight
377.44
References & Citations
[1]Alshammari E, et al. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer. World J Gastroenterol. 2022 Aug 7;28 (29) :3753-3766. |[2]Thomenius MJ, et al. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation. PLoS One. 2018 Jun 1;13 (6) :e0197372.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC401969 20 µg
Fuc-TIX (FUT9) (NM_006581) Human Over-expression Lysate
Sign In for Pricing
View Details